Drug Discovery World

Belkins
Welcome to our LinkedIn page. This is where we will share articles from our lastest issues, as well as news and other company updates. Now in its 18th year, DDW is the only truly global business review of all aspects of drug discovery and development and has firmly established itself as a highly respected and ‘must read’ journal within the discovery and development arena. DDW is renowned for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised ‘platform’ for ‘Industry Gurus’ to discuss and encourage debate on some of the more challenging issues surrounding the technological, strategic and business facets of the pharma and biopharmaceutical industry. DDW has always adhered to the maxim.’Turning Science into Business’.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

RESEARCH

MINDMED SIGNS PARTNERSHIP WITH SWISS PSYCHEDELIC DRUG DISCOVERY STARTUP MINDSHIFT COMPOUNDS AG

MindMed | February 15, 2021

news image

MindMed, a leading psychedelic medicine biotech company announced another partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic compounds with psychedelic or empathogenic properties. As a component of this partnership, MindMed and MindShift Compounds AG have agreed to develop next-gen psychedelic and empathogenic substances together. The first initial compounds have just been combined by MindShift Compounds AG and related patent applicati...

Read More

PHARMA TECH

INNOVACARE SIGNS AGREEMENT WITH MEDAVAIL TO OPEN THREE SPOTRX LOCATIONS IN FLORIDA

InnovaCare | November 09, 2021

news image

MedAvail Holdings, Inc. a technology-enabled retail pharmacy company, will be opening an initial three SpotRx locations with InnovaCare Health in Florida in the fourth quarter of 2021. In-clinic SpotRx kiosks and courier home delivery, supported by onsite SpotRx clinic account managers, will be available to patients at three Trinity Medical Center clinics in the Lakeland area. Trinity Medical Center is part of the InnovaCare Health clinical network. SpotRx Pharmacy is the retail p...

Read More

BEIGENE REPORTS POSITIVE PHASE III INTERIM ANALYSIS FOR LUNG CANCER DRUG

MedCity News | April 14, 2020

news image

Interim results from a Phase III clinical trial have shown that patients receiving a cancer immunotherapy drug for a form of lung cancer on top of chemotherapy were more likely than those receiving chemotherapy alone to survive without their disease worsening, the company developing the drug said Monday. Beijing-based BeiGene reported an improvement in progression-free survival (PFS) among first-line patients with non-squamous non-small-cell lung cancer (NSCLC) receiving tislelizumab along with ...

Read More

PHARMA TECH

WINHEALTH AND IMMEDICA ENTER INTO AN AGREEMENT THAT GIVES WINHEALTH THE RIGHTS TO RAVICTI® IN CHINA AND SEVERAL OTHER ASIA-PACIFIC COUNTRIES

WinHealth | January 04, 2021

news image

Hong Kong WinHealth Pharma Group Co., Ltd. furthermore, Immedica Pharma AB, today declared that they have gone into an understanding under which WinHealth has the restrictive business rights to Ravicti® (Glycerol Phenylbutyrate) for Greater China, South Korea, Singapore, Vietnam , Indonesia, Malaysia , the Philippines and Thailand gets. Ravicti® is shown for the treatment of urea cycle issue (UCD) in Europe and North America, and as a feature of the reported association, W...

Read More

RESEARCH

MindMed | February 15, 2021

news image

MINDMED SIGNS PARTNERSHIP WITH SWISS PSYCHEDELIC DRUG DISCOVERY STARTUP MINDSHIFT COMPOUNDS AG

MindMed, a leading psychedelic medicine biotech company announced another partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic compounds with psychedelic or empathogenic properties. As a component of this partnership, MindMed and MindShift Compounds AG have agreed to develop next-gen psychedelic and empathogenic substances together. The first initial compounds have just been combined by MindShift Compounds AG and related patent applicati...

Read More

PHARMA TECH

InnovaCare | November 09, 2021

news image

INNOVACARE SIGNS AGREEMENT WITH MEDAVAIL TO OPEN THREE SPOTRX LOCATIONS IN FLORIDA

MedAvail Holdings, Inc. a technology-enabled retail pharmacy company, will be opening an initial three SpotRx locations with InnovaCare Health in Florida in the fourth quarter of 2021. In-clinic SpotRx kiosks and courier home delivery, supported by onsite SpotRx clinic account managers, will be available to patients at three Trinity Medical Center clinics in the Lakeland area. Trinity Medical Center is part of the InnovaCare Health clinical network. SpotRx Pharmacy is the retail p...

Read More

MedCity News | April 14, 2020

news image

BEIGENE REPORTS POSITIVE PHASE III INTERIM ANALYSIS FOR LUNG CANCER DRUG

Interim results from a Phase III clinical trial have shown that patients receiving a cancer immunotherapy drug for a form of lung cancer on top of chemotherapy were more likely than those receiving chemotherapy alone to survive without their disease worsening, the company developing the drug said Monday. Beijing-based BeiGene reported an improvement in progression-free survival (PFS) among first-line patients with non-squamous non-small-cell lung cancer (NSCLC) receiving tislelizumab along with ...

Read More

PHARMA TECH

WinHealth | January 04, 2021

news image

WINHEALTH AND IMMEDICA ENTER INTO AN AGREEMENT THAT GIVES WINHEALTH THE RIGHTS TO RAVICTI® IN CHINA AND SEVERAL OTHER ASIA-PACIFIC COUNTRIES

Hong Kong WinHealth Pharma Group Co., Ltd. furthermore, Immedica Pharma AB, today declared that they have gone into an understanding under which WinHealth has the restrictive business rights to Ravicti® (Glycerol Phenylbutyrate) for Greater China, South Korea, Singapore, Vietnam , Indonesia, Malaysia , the Philippines and Thailand gets. Ravicti® is shown for the treatment of urea cycle issue (UCD) in Europe and North America, and as a feature of the reported association, W...

Read More